Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 917-922

Bentham Science Publishers

Access to resources Recommend Favorite

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio   Armentero Marie-Therese  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

New amino derivatives of 1,2,3-triazolo[4,5-d]pyrimidines and their affinity towards A 1 and A 2A adenosine receptors

By Betti L.   Biagi G.   Giannaccini G.   Giorgi I.   Livi O.   Lucacchini A.   Manera C.   Scartoni V.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 10, 1999-10 ,pp. : 867-875

Elsevier

Access to resources Recommend Favorite

Allosteric Enhancers of A1 Adenosine Receptors: State of the Art and New Horizons for Drug Development

By  

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3488-3502

Bentham Science Publishers

Access to resources Recommend Favorite

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 148-157

Bentham Science Publishers

Access to resources Recommend Favorite